HR 8601 United States House · 118th Congress

Liver Illness Visibility, Education, and Research Act of 2024

This bill establishes new federal funding and structural changes to address liver cancer and liver disease disparities. It allocates $45 million annually for liver cancer research, $90 million for prevention and patient tracking programs targeting high-risk communities, and $10 million for culturally appropriate awareness campaigns. The legislation redesignates the National Institute of Diabetes and Digestive and Kidney Diseases as the National Institute of Diabetes and Digestive, Kidney, and Liver Diseases, creating a new Division of Liver Diseases within the institute. It specifically aims to address higher liver cancer rates among Asian-American, Pacific Islander, and Hispanic communities, which are disproportionately affected by hepatitis B. Key provisions include creating a National Liver Diseases Data System and requiring community consultation for outreach programs.
Bill status in committee 1 of 4 stages cleared
Introduction
Jun 2024
Committee Review
Floor Vote
President
Introduced Jun 3, 2024 Last action Jun 7, 2024
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
0
Committee
2
Jun 7, 2024
Committee
Referred to the Subcommittee on Health.
lower
Jun 3, 2024
Committee
Referred to the House Committee on Energy and Commerce.
lower
Jun 3, 2024
Introduced
Introduced in House
lower
1 primary · 7 co-sponsors

Sponsors